Evidence map›Paper›PMID 9794788›Full record

ArticleThe Biochemical journal1998

Stimulation of the Ca2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A.

A Schaefer, M Magócsi, A Fandrich, H Marquardt

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

A SchaeferDepartment of Toxicology, Hamburg University Medical School and Fraunhofer Department of Toxicology and Environmental Medicine, Grindelallee 117, D-20146 Hamburg, Germany. aschaefe@uke.uni-hamburg.de
M Magócsi
A Fandrich
H Marquardt
Universität Hamburg · DEHungarian National Blood Transfusion Service · HUMSH Medical School Hamburg – University of Applied Sciences and Medical University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Ca2+-induced expression of the primary response genes egr-1 and c-fos was investigated in the murine erythroleukaemia cell line ELM-I-1. Exposure of the cells to the Ca2+-ionophore A23187 led to a rapid transient rise in egr-1 and c-fos mRNA production followed by an increase in Egr-1 and c-Fos protein levels as well as an increase in Egr-1 and activator protein 1 (AP-1) DNA-binding activity. Preincubation of the cells with KN-62, a specific inhibitor of Ca2+/calmodulin-dependent protein kinases, strongly decreased the Ca2+-mediated expression of egr-1 and c-fos. In contrast, treatment with cyclosporin A, which inhibits the Ca2+/calmodulin-dependent protein phosphatase 2B or calcineurin, increased both egr-1 and c-fos mRNA production and the DNA-binding activity of the Egr-1 and AP-1 transcription factors in response to the intracellular Ca+ concentration ([Ca2+]i)-increasing agents A23187 or cyclopiazonic acid. Enhancement of the Ca2+-induced c-fos and egr-1 expression by cyclosporin A was correlated with the capability of this agent to inhibit calcineurin phosphatase activity in ELM-I-1 cells. Studies on the phosphorylation state and DNA-binding activity of the cAMP response element-binding protein (CREB) did not demonstrate an early Ca2+-dependent activation of this transcription factor, suggesting that the regulation of c-fos and egr-1 expression by Ca2+ is not linked to CREB in the haematopoietic ELM-I-1 cells. The results indicate that calcineurin exerts negative regulatory effects on both egr-1 and c-fos expression in murine erythroleukaemia cells, in addition to the calcineurin-mediated down-regulation of c-myb expression observed previously in this cell system. This study therefore emphasizes the important role of calcineurin as a negative modulator of gene expression in certain cell types.

Indexed as

Genes, fosTranscription, GeneticAnimalsCalcimycinCalcineurin InhibitorsCalciumCalcium-Calmodulin-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinCyclosporineDNA-Binding ProteinsEarly Growth Response Protein 1Gene Expression Regulation, NeoplasticImmediate-Early ProteinsLeukemia, Erythroblastic, AcuteMiceProtein Tyrosine PhosphatasesCalcimycinCalcineurin InhibitorsCalciumCalcium-Calmodulin-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinCyclosporineDNA-Binding ProteinsEarly Growth Response Protein 1Egr1 protein, mouseImmediate-Early ProteinsProtein Tyrosine PhosphatasesProto-Oncogene Proteins c-fosRNA, MessengerTacrolimusTranscription Factor AP-1Transcription Factors

Identifiers

PMID9794788
PMCPMC1219809
OpenAlexW1849480711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.